I. Amri

Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection

F. Carrat, S. Pol, N. Lapidus, 2018, Pharmacoepidemiology and drug safety.

Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial

S. Urien, N. Bouazza, J. Warszawski, 2020, Antimicrobial Agents and Chemotherapy.

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Prevalence and Characteristics of Individuals With Undiagnosed HIV Infection in France: Evidence From a Survey on Hepatitis B and C

L. Meyer, C. Goujard, M. Chaix, 2018 .

Thrombocytopenia during primary HIV-1 infection predicts the risk of recurrence during chronic infection.

F. Raffi, L. Meyer, C. Goujard, 2012, Journal of acquired immune deficiency syndromes.

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)

C. Charpentier, F. Brun-Vézinet, R. Tubiana, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

V. de Lédinghen, Y. Yazdanpanah, D. Neau, 2018, HIV medicine.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

C. Katlama, M. Shoai, H. Melliez, 2018, The Journal of antimicrobial chemotherapy.